Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system (CNS) agents and receptor antagonists. Its structure supports the creation of bioactive molecules due to the presence of both piperazine and nitroaryl groups, which are common motifs in medicinal chemistry. Commonly employed in research settings for constructing drug candidates targeting neurological and psychiatric disorders. Also utilized in the preparation of fluorinated analogs to improve metabolic stability and binding affinity in drug design.